Naqi Logix launches $15 million Reg A+ offering

Naqi Logix has opened a $15 million Regulation A+ equity offering to accredited and non-accredited investors as it looks to fund its AI-neurotechnology platform. The Vancouver company plans to use the proceeds for product development, commercialization, research and working capital.

Why it matters: - Naqi Logix is trying to raise capital for a non-invasive human-machine interface that aims to replace screens, keyboards, voice commands and implants with more natural digital control. - The Reg A+ structure broadens access beyond accredited investors, giving qualified non-accredited investors a path into the offering. - The company is using the raise to push its AI-neurotechnology platform toward commercialization.

What happened: - Naqi Logix Inc. launched a $15 million Regulation A+ equity offering. - The offering is open to both accredited investors and non-accredited investors. - The company filed the offering with the U.S. Securities and Exchange Commission. - The announcement was made July 14, 2026, from Vancouver, British Columbia.

The details: - The offering price is $2.61 per common share. - Investments of $1,000 or more receive bonus shares in escalating amounts tied to the investment size. - The minimum investment is $522, equal to 200 common shares. - Naqi intends to use proceeds for continued development of its AI-neurotechnology platform, commercialization initiatives, research and development, and working capital. - Naqi’s platform combines artificial intelligence with neurotechnology to create a non-invasive human-machine interface. - The system is designed to support natural control of digital systems across computers, mobile devices, robotics and connected environments. - Naqi says its earbud-based interface captures biosignals and uses proprietary AI to interpret intent. - The platform turns subtle facial micro-gestures and head movements into real-time digital commands. - The company says the system is camera-free, safe, private and does not require hands, voice, screens or implants. - The offering is available through Dealmaker Securities LLC, a FINRA/SIPC member. - The company says accredited investors are not limited in the amounts they may invest. - Non-accredited investors may invest no more than 10% of the greater of annual income or net worth for individuals, or 10% of the greater of annual revenue or net assets at fiscal year-end for entities. - The investment is speculative and illiquid and carries the risk of losing the entire investment. - The company retains the right to continue the offering beyond the termination date at its sole discretion. - Offering details and the offering circular are filed with the SEC and available in the Naqi Reg A Offering. - The company also directs investors to learn more on how to invest.

Between the lines: - Naqi is positioning its technology as a privacy-focused alternative to mainstream human-computer interfaces. - The Reg A+ format suggests the company wants to reach a wider retail investor base while still marketing the raise as part of a broader technology rollout. - The heavy risk disclosures underline that this is an early-stage, speculative financing tied to future product and regulatory progress.

What's next: - Naqi will use the offering proceeds to keep developing the platform and pursue commercialization. - Future results will depend on customer demand, financing conditions, technical progress and regulatory requirements for medical applications. - The company says it may extend the offering beyond the stated termination date if it chooses to do so. - Investors can review the filing materials through the SEC and the Naqi Reg A Offering.